# Noom's GLP-1 Program Pairs Medication with Behavioral Support
Noom Med has launched a GLP-1 prescription program that combines appetite-suppressing medications with the company's established behavioral coaching approach. The program positions itself as a comprehensive weight management solution that addresses both the pharmacological and psychological sides of weight loss.
GLP-1 receptor agonists like semaglutide and tirzepatide have become popular for weight loss, but Noom's addition of behavioral coaching distinguishes the offering. The company frames this integration as essential, since medication alone doesn't guarantee sustained results. Users receive customized meal planning, exercise recommendations, and coaching focused on building lasting habits.
The program works through Noom's digital platform, which connects users with healthcare providers who manage prescriptions and monitor progress. Users can track food intake, exercise, and weight changes while receiving feedback from the app and coaches. This integration allows providers to adjust medications based on individual response and side effects.
Research shows behavioral interventions enhance medication outcomes for weight loss. Studies published in obesity journals demonstrate that patients receiving both medication and behavioral support lose more weight and maintain losses longer than those receiving medication alone. Noom's approach targets this evidence-based model by treating GLP-1 therapy as one component within a broader lifestyle framework.
The program represents a shift in how digital health companies approach weight management. Rather than positioning telehealth prescription services as standalone solutions, Noom integrates them into existing coaching infrastructure. This means users don't simply receive medications; they work with coaches trained in habit formation and behavioral change.
For people considering GLP-1 medications, this model offers structure and accountability that self-managed prescriptions often lack. However, the program's effectiveness ultimately depends on individual adherence to coaching recommendations and tolerance of medication side effects. The combination works best for those willing to engage with both the pharmacological